Arthroplasty, Replacement, Hip Clinical Trial
Official title:
Home-based Rehabilitation Following a Total Hip Replacement - do Patients Follow the Exercise Prescription and How Does it Relate to Postoperative Recovery? The Pragmatic Home-Based Exercise After Total Hip Arthroplasty Silkeborg 1 (PHETHAS-1) Trial
In this study we will investigate the relation between performed exercise dose and recovery
after total hip replacement (THA). A dose-response relationship is hypothesized.
It is the primary objective to indicate the preliminary efficacy of home-based rehabilitation
using elastic band exercise on performance-based function after THA, based on the
relationship between the performed exercise dose (objectively quantified time under tension
summary dose) and the change in 40 meter maximal gait speed (performance-based function) from
3 (start of intervention) to 10 weeks (end of intervention) after surgery.
The study is a pragmatic, single center, prospective cohort study (single cohort) to be
conducted in Silkeborg, Denmark. The outcomes will be collected in the period from 3 to 10
weeks after surgery by an assessor blinded to exercise compliance. The study will adhere
methodologically to the STROBE guidelines and checklist for prospective cohort studies
(www.strobe-statement.org).
The study design and completion is conducted in a research collaboration between the
Interdisciplinary Research Unit at Elective Surgery Centre based at Silkeborg Regional
Hospital and Physical Medicine & Rehabilitation Research - Copenhagen (PMR-C) based at
Hvidovre Hospital.
Primary objective, eligibility criteria, exposure/intervention and outcome measures are
entered elsewhere. At June 28, 2017, two outcome measures were added to the study. At 10
weeks after surgery, patients will be asked both to describe change in hip problems (from
preoperatively to 10 weeks after surgery) and to describe their perception of outcome after
surgery. The outcome measures will be used for exploratory analysis of patient acceptable
symptom state (PASS) and minimal clinically important improvement (MCII)
Primary analysis:
A simple linear regression analysis will be performed to evaluate the association between
performed exercise dose and change in score on gait speed. Furthermore descriptive statistics
will be used to quantify exercise compliance and to indicate the exercise dosage with the
greatest response. Patients will be divided into four compliance-quartiles and summary
statistics of the primary outcome (change in gait speed) will be presented graphically to
illustrate possible dose-response relationship.
Secondary analyses:
For change in patient-reported function the analysis will be similar to the analysis for
change in gait speed. Summary statistics on the rest of the secondary outcomes will be
presented for the compliance-quartiles.
In a multiple regression analysis the association between gait speed (at 10 weeks follow up)
and self-efficacy, 24-hour physical activity, performed exercise dose and gait speed (at
baseline) will be analyzed.
Furthermore summary statistics will be presented for demographic data and other pre-specified
outcomes.
Additionally, an embedded qualitative study will be performed to explore motivation and
barriers related to exercise compliance. This study will be reported in a secondary paper
with a clear reference to the primary trial and trial registration.
Regional Hospital Central Jutland and The Danish Rheumatism Association is partly funding the
salary for physiotherapists involved in the study. Further external funding will be applied
for.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Recruiting |
NCT03746925 -
Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches
|
N/A | |
Completed |
NCT03008967 -
A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark
|
N/A | |
Completed |
NCT00980616 -
Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA)
|
Phase 2 | |
Not yet recruiting |
NCT00958945 -
Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements
|
N/A | |
Completed |
NCT04542174 -
PMCF 8 Year Results TRJ®
|
||
Not yet recruiting |
NCT04019925 -
Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis
|
N/A | |
Recruiting |
NCT06102811 -
Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT03570944 -
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
|
||
Recruiting |
NCT02938962 -
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
|
Phase 4 | |
Completed |
NCT03076827 -
Effects of Surgery Start Time on Postoperative Interleukin-6, Interleukin-8, and Cortisol
|
N/A | |
Recruiting |
NCT02385383 -
An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study
|
N/A | |
Completed |
NCT01444586 -
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
|
N/A | |
Terminated |
NCT02525627 -
A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads
|
N/A | |
Completed |
NCT00808483 -
Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty
|
N/A | |
Terminated |
NCT00958347 -
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
|
N/A | |
Completed |
NCT01422304 -
Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)
|
Phase 3 | |
Completed |
NCT04332055 -
RCT Measuring the Effect of the ERVIN Software
|
N/A | |
Completed |
NCT01257568 -
Rejuvenate Modular Outcomes Study
|
N/A | |
Recruiting |
NCT01031732 -
Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty
|
N/A |